Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Long-Term Investments: 2024

Historic Long-Term Investments for Dianthus Therapeutics (DNTH) over the last 1 years, with Dec 2024 value amounting to $81.7 million.

  • Dianthus Therapeutics' Long-Term Investments rose 148.65% to $152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.9 million, marking a year-over-year increase of 148.65%. This contributed to the annual value of $81.7 million for FY2024, which is N/A change from last year.
  • Dianthus Therapeutics' Long-Term Investments amounted to $81.7 million in FY2024.
  • Dianthus Therapeutics' 5-year Long-Term Investments high stood at $81.7 million for FY2024, and its period low was $81.7 million during FY2024.
  • In the last 1 years, Dianthus Therapeutics' Long-Term Investments had a median value of $81.7 million in 2024 and averaged $81.7 million.